Business Description
Valneva SE
SIC : 2836
ISIN : FR0004056851
Total Employee Number:
674Compare
Compare
Traded in other countries / regions
VLA.FranceVALN.USA0OB3.UKAYJ.GermanyVLA.AustriaAYJ.Bulgaria IPO Date
2007-07-13Description
Valneva SE is a French biotech company that develops, manufactures, and commercializes vaccines for infectious diseases with unmet medical needs. Its marketed portfolio includes IXIARO, a vaccine against Japanese encephalitis; DUKORAL, an oral vaccine against cholera and travelers' diarrhea; and IXCHIQ, the first approved vaccine against chikungunya. The company also has research and development programs targeting Lyme disease and other pathogens, often pursued through partnerships with larger pharmaceutical firms. Valneva sells its products through distributors, travel clinics, and public health authorities, generating most revenue from product sales, supplemented by collaboration and licensing income. It operates manufacturing facilities in Sweden and Scotland and serves markets across Europe, North America, and Asia. The company is headquartered in Saint-Herblain, France, and is listed on Euronext Paris and the Nasdaq Global Select Market.
Financial Strength
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.58 | |||||
Equity-to-Asset | 0.21 | |||||
Debt-to-Equity | 2.59 | |||||
Debt-to-EBITDA | -1.8 | |||||
Piotroski F-Score | 1/9 | |||||
Altman Z-Score | -1.86 | |||||
Beneish M-Score | -2.97 | |||||
WACC vs ROIC | ||||||
Growth Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -30.8 | |||||
3-Year EBITDA Growth Rate | 30.8 | |||||
3-Year EPS without NRI Growth Rate | 14.4 | |||||
3-Year FCF Growth Rate | 47.7 | |||||
3-Year Book Growth Rate | -27.2 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 16.55 |
Momentum Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 49.07 | |||||
9-Day RSI | 51.77 | |||||
14-Day RSI | 55.35 | |||||
3-1 Month Momentum % | 27.44 | |||||
6-1 Month Momentum % | -38.72 | |||||
12-1 Month Momentum % | -32.56 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 2.16 | |||||
Quick Ratio | 1.69 | |||||
Cash Ratio | 1.18 | |||||
Days Inventory | 168 | |||||
Days Sales Outstanding | 49.26 | |||||
Days Payable | 47.41 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -7.8 | |||||
Shareholder Yield % | -6.32 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 16.4 | |||||
Operating Margin % | -80.39 | |||||
Net Margin % | -110.29 | |||||
EBITDA Margin % | -81.83 | |||||
FCF Margin % | -61.06 | |||||
OCF Margin % | -59.42 | |||||
ROE % | -131.18 | |||||
ROA % | -37.9 | |||||
ROIC % | -45.66 | |||||
3-Year ROIIC % | -18.07 | |||||
ROC (Joel Greenblatt) % | -68.62 | |||||
ROCE % | -38.65 | |||||
Years of Profitability over Past 10-Year | 1 | |||||
Moat Score | 6 | |||||
Tariff Resilience Score | 6 |
GF Value Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Forward PE Ratio | 9.74 | |||||
PS Ratio | 3.5 | |||||
PB Ratio | 6.59 | |||||
Price-to-Tangible-Book | 8.88 | |||||
EV-to-EBIT | -5.29 | |||||
EV-to-EBITDA | -5.29 | |||||
EV-to-Revenue | 4.33 | |||||
EV-to-Forward-Revenue | 1.74 | |||||
EV-to-FCF | -10.96 | |||||
Price-to-GF-Value | 1.23 | |||||
Price-to-Median-PS-Value | 1.41 | |||||
Earnings Yield (Greenblatt) % | -18.88 | |||||
FCF Yield % | -10.93 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Valneva SE Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 142.938 | ||
| EPS (TTM) (€) | -0.898 | ||
| Beta | 2.0569 | ||
| 3-Year Sharpe Ratio | -0.16 | ||
| 3-Year Sortino Ratio | -0.23 | ||
| Volatility % | 76.78 | ||
| 14-Day RSI | 55.35 | ||
| 14-Day ATR (€) | 0.104081 | ||
| 20-Day SMA (€) | 2.85325 | ||
| 12-1 Month Momentum % | -32.56 | ||
| 52-Week Range (€) | 2.032 - 5.26 | ||
| Shares Outstanding (Mil) | 189.65 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 1 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Valneva SE Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Valneva SE Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| Fourth quarter earnings conference call for 2026 | 2027-03-18 10:00 | In 178 days | ||
| Fourth quarter earnings results for 2026 | 2027-03-18 | In 177 days | ||
| Annual report for 2026 | 2027-03-17 | In 176 days | ||
| Third quarter earnings conference call for 2026 | 2026-11-20 09:00 | In 60 days | ||
| Third quarter earnings results for 2026 | 2026-11-20 | In 59 days | ||
| Second quarter earnings conference call for 2026 | 2026-08-13 09:00 | 2.43 (-4.26%) | ||
| Second quarter earnings results for 2026 | 2026-08-13 | 2.43 (-4.26%) | ||
| General meeting for 2026 | 2026-06-25 14:00 | 2.30 (-0.86%) | ||
| Jefferies Global Healthcare Conference | 2026-06-03 11:40 | 2.43 (-2.99%) | ||
| First quarter earnings conference call for 2026 | 2026-05-13 09:00 | 2.56 (-7.59%) |
Show
Entries
Valneva SE Frequently Asked Questions
What is Valneva SE(STU:AYJ)'s stock price today?
The current price of STU:AYJ is €2.84. The 52 week high of STU:AYJ is €5.26 and 52 week low is €2.03.
When is next earnings date of Valneva SE(STU:AYJ)?
The next earnings date of Valneva SE(STU:AYJ) is 2026-11-20 Est..
Does Valneva SE(STU:AYJ) pay dividends? If so, how much?
Valneva SE(STU:AYJ) does not pay dividend.
Press Release
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers